awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28087213-2BB89AD2-56D8-419E-92E5-2C7FCD83145E
Q28087213-2BB89AD2-56D8-419E-92E5-2C7FCD83145E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28087213-2BB89AD2-56D8-419E-92E5-2C7FCD83145E
Secondary mutations as mediators of resistance to targeted therapy in leukemia
P2860
Q28087213-2BB89AD2-56D8-419E-92E5-2C7FCD83145E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28087213-2BB89AD2-56D8-419E-92E5-2C7FCD83145E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
389aa2c87a3b94bcb5e68f14cb9be00e21bfcddd
P2860
Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.